CABALETTA BIO INC's ticker is CABA and the CUSIP is 12674W109. A total of 54 filers reported holding CABALETTA BIO INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $280,145 | +157.0% | 30,286 | -82.0% | 0.07% | +209.1% |
| Q3 2022 | $109,000 | -89.1% | 168,623 | -82.1% | 0.02% | -87.9% |
| Q2 2022 | $1,000,000 | -66.5% | 944,431 | -35.7% | 0.18% | -53.6% |
| Q1 2022 | $2,982,000 | -43.5% | 1,469,070 | +5.4% | 0.39% | -50.2% |
| Q4 2021 | $5,281,000 | -63.4% | 1,393,398 | +17.3% | 0.79% | -22.6% |
| Q3 2021 | $14,445,000 | +77.3% | 1,187,898 | +25.4% | 1.02% | +54.6% |
| Q2 2021 | $8,145,000 | +88.4% | 947,128 | +143.2% | 0.66% | +353.8% |
| Q1 2021 | $4,323,000 | – | 389,384 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 2,106,000 | $32,053,320 | 21.20% |
| COMMODORE CAPITAL LP | 2,525,753 | $38,441,961 | 4.49% |
| Bain Capital Life Sciences Investors, LLC | 2,000,000 | $30,440,000 | 3.40% |
| VR Adviser, LLC | 1,973,253 | $30,032,911 | 3.16% |
| Cormorant Asset Management, LP | 2,879,424 | $43,824,833 | 2.56% |
| Velan Capital Investment Management LP | 150,000 | $2,283,000 | 1.84% |
| Redmile Group, LLC | 1,774,252 | $27,004,115 | 1.28% |
| TCG Crossover Management, LLC | 486,795 | $7,409,020 | 1.09% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,340,118 | $35,616,596 | 0.78% |
| Integral Health Asset Management, LLC | 330,000 | $5,022,600 | 0.70% |